Supervised Machine Learning Methods and Hyperspectral Imaging Techniques Jointly Applied for Brain Cancer Classification.
Gemma UrbanosAlberto MartínGuillermo VázquezMarta VillanuevaManuel VillaLuis Jimenez-RoldanMiguel ChavarriasAlfonso LagaresEduardo JuarezCesar SanzPublished in: Sensors (Basel, Switzerland) (2021)
Hyperspectral imaging techniques (HSI) do not require contact with patients and are non-ionizing as well as non-invasive. As a consequence, they have been extensively applied in the medical field. HSI is being combined with machine learning (ML) processes to obtain models to assist in diagnosis. In particular, the combination of these techniques has proven to be a reliable aid in the differentiation of healthy and tumor tissue during brain tumor surgery. ML algorithms such as support vector machine (SVM), random forest (RF) and convolutional neural networks (CNN) are used to make predictions and provide in-vivo visualizations that may assist neurosurgeons in being more precise, hence reducing damages to healthy tissue. In this work, thirteen in-vivo hyperspectral images from twelve different patients with high-grade gliomas (grade III and IV) have been selected to train SVM, RF and CNN classifiers. Five different classes have been defined during the experiments: healthy tissue, tumor, venous blood vessel, arterial blood vessel and dura mater. Overall accuracy (OACC) results vary from 60% to 95% depending on the training conditions. Finally, as far as the contribution of each band to the OACC is concerned, the results obtained in this work are 3.81 times greater than those reported in the literature.
Keyphrases
- machine learning
- convolutional neural network
- deep learning
- high grade
- artificial intelligence
- big data
- high resolution
- ejection fraction
- low grade
- systematic review
- newly diagnosed
- end stage renal disease
- healthcare
- climate change
- prognostic factors
- papillary thyroid
- multidrug resistant
- radiation induced
- peritoneal dialysis
- coronary artery bypass
- squamous cell carcinoma
- coronary artery disease
- multiple sclerosis
- patient reported outcomes
- radiation therapy
- young adults
- photodynamic therapy
- percutaneous coronary intervention
- childhood cancer